ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus

Citation
Gf. Rimmelzwaan et al., ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus, VACCINE, 17(11-12), 1999, pp. 1355-1358
Citations number
7
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
17
Issue
11-12
Year of publication
1999
Pages
1355 - 1358
Database
ISI
SICI code
0264-410X(19990317)17:11-12<1355:IVIPAA>2.0.ZU;2-G
Abstract
Recently avian influenza A viruses of the H5N1 subtype were shown to infect humans in the Hong Kong area, resulting in the death of six people. Althou gh these viruses did not efficiently spread amongst humans, these events il lustrated that influenza viruses of subtypes not previously detected in hum ans could be at the basis of a new pandemic. In the light of this pandemic threat we evaluated and compared the efficacy of a classical non-adjuvanted subunit vaccine and a vaccine based on immune stimulating complexes (ISCOM ) prepared with the membrane glycoproteins of the human influenza virus A/H ong Kong/156/97 (H5N1) to protect roosters against a lethal challenge with this virus. The ISCOM vaccine induced protective immunity against the chall enge infection whereas the non-adjuvanted subunit vaccine proved to be poor ly immunogenic and failed to induce protection in this model. (C) 1999 Else vier Science Ltd. All rights reserved.